Literature DB >> 23466181

Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy).

M Trento1, F Panero, M Porta, G Gruden, F Barutta, F Cerutti, R Gambino, M Perotto, P Cavallo Perin, G Bruno.   

Abstract

BACKGROUND AND AIMS: Type 1 diabetes (T1DM) affects young people during the most active years of their life. Our aim was to assess quality of life (QoL) and associated variables in a large cohort of adults with childhood-onset and adult-onset T1DM.
METHODS: A cohort of adult patients (18 years and older) from the T1DM Registry of Turin, Italy, was recruited. Clinical characteristics and Diabetes QoL (DQOL) questionnaire were assessed by standardized procedures.
RESULTS: 310 adults completed the questionnaire. Age and diabetes duration at assessment (mean ± SD) were 32.8 ± 7.3 years and 17.3 ± 6.3 years, respectively. DQOL and its subscores were in the lower quartiles of their distributions, indicating a good level of QoL. However, scores were significantly higher in females than in males, particularly for the subscale of diabetes-related worries. In multivariate analysis, lower QoL was independently associated with female sex (β = 1.07, 95% CI 1.03-1.11, p = 0.003), higher age at onset (β = 1.03, 1.00-1.05, p = 0.009), lower schooling (β = 1.05, 1.00-1.09, p = 0.02), higher fasting plasma glucose (β = 1.03, 1.01-1.05, p = 0.008), daily SMBG >4 (β = 1.06, 1.01-1.10, p = 0.01), severe hypoglycemia over the last year (β = 1.06, 1.01-1.11, p = 0.02), lower numbers of diabetologic visits (β = 1.07, 1.01-1.13, p = 0.02) and hypertension (β = 1.06, 1.02-1.10, p = 0.005). Autonomic neuropathy was associated with diabetes impact. Female sex (β = 4.36, 2.43-7.83) and daily SMBG >4 (β = 3.77, 1.72-8.30) were independently associated with worst level and CSII with better level (β = 0.22, 0.07-0.68) of diabetes-related worries.
CONCLUSIONS: The impact of T1DM on QoL may depend on demographic, metabolic control-related variables, presence of complications and insulin delivery modality.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemiology; Quality of life; Registry; Type 1 diabetes

Mesh:

Substances:

Year:  2013        PMID: 23466181     DOI: 10.1016/j.numecd.2013.01.004

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Monetary reinforcement for self-monitoring of blood glucose among young people with type 1 diabetes: evaluating effects on psychosocial functioning.

Authors:  J J Wong; A Addala; D Naranjo; K K Hood; E Cengiz; M K Ginley; R S Feinn; J A Wagner
Journal:  Diabet Med       Date:  2019-11-19       Impact factor: 4.359

2.  Gender differences in quality of life in adults with long-standing type 1 diabetes mellitus.

Authors:  Ana María Castellano-Guerrero; Raquel Guerrero; Desireé Ruiz-Aranda; Sofia Perea; Alfonso Pumar; Federico Relimpio; Miguel Angel Mangas; Fernando Losada; Maria Asunción Martínez-Brocca
Journal:  Diabetol Metab Syndr       Date:  2020-07-17       Impact factor: 3.320

3.  Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes.

Authors:  Marie M Henriksen; Henrik U Andersen; Birger Thorsteinsson; Ulrik Pedersen-Bjergaard
Journal:  Diabetologia       Date:  2021-01-14       Impact factor: 10.122

4.  Quality of life and type 1 diabetes: a study assessing patients' perceptions and self-management needs.

Authors:  Dácil Alvarado-Martel; Rebeca Velasco; Rosa M Sánchez-Hernández; Armando Carrillo; Francisco Javier Nóvoa; Ana María Wägner
Journal:  Patient Prefer Adherence       Date:  2015-09-14       Impact factor: 2.711

5.  The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study.

Authors:  Giuseppina T Russo; Marina Scavini; Elena Acmet; Erminio Bonizzoni; Emanuele Bosi; Francesco Giorgino; Antonio Tiengo; Domenico Cucinotta
Journal:  Diabetes Technol Ther       Date:  2016-06-21       Impact factor: 6.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.